Illumina Secures China National Drug Administration Clearanc

Industry news | 30 August, 2018 | CACLP

Illumina said recently that it has received regulatory clearance for its MiSeqDx system from the China National Drug Administration, enabling it to sell the system in China for diagnostic testing.

"The clearance of the MiSeqDx in China is a significant milestone for Illumina because it provides more opportunities for NGS," Garret Hampton, executive vice president of clinical genomics at Illumina, said in a statement. "More medical institutions and patients will now have access to the latest NGS technology."

Previously, Illumina partnered with Berry Genomics to garner regulatory clearance for a noninvasive prenatal test to be run on a version of Illumina's NextSeq instrument developed specifically for diagnostic use in China.

The approval of the MiSeqDx instrument, by contrast, was not tied to a specific assay. Illumina said it can now market and sell the system to hospitals and other medical institutions for in vitro diagnostic testing throughout China.

Filed under：

national health

Press contact

CACLP - The largest IVD Expo & Conference

Back to list

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

Name *
Email *
Company name *
Country *

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

No, thanks. Yes, I agree.

Subscribe to CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.

Name *
Email *
Telephone
Job title
Company name *
Country *

By submitting the form here, you agree to our Privacy Policy and agree that we may store and access the information you provide.

Illumina Secures China National Drug Administration Clearanc

Most popular

MGI Tech Partners with Dasa to Enhance Health Diagnosis with Genetic Sequencing in Brazil

Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial Use of Liquid Biopsy Assay

LuminUltra Acquires Legionella Testing Business from Genomadix and Inks Strategic License to Commercialize Additional Tests for Ultra-portable Molecular Diagnostic Platform

Stay in touch with CACLP News

Subscribe to CACLP News

Thank you for subscribing to CACLP News!